Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-approval of Coaptite® in the Treatment of Female Urinary Incontinence

NCT00996489 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT00996489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00996489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-approval of Coaptite® in the Treatment of Female Urinary Incontinence
Lead sponsor
Merz North America, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2008
Completion date
November 2, 2015
Enrollment
459 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

female stress urinary incontinence due to intrinsic sphincter deficiency